The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple MyelomaSzymon Zmorzyński, Agata Filip, Sylwia Popek-Marciniec et al.|Frontiers in Oncology|2019Cited by 38
ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple MyelomaSzymon Zmorzyński, Agata Filip, Joanna Januszewska et al.|Frontiers in Oncology|2019Cited by 36
Serum brain‐derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patientsAneta Szudy‐Szczyrek, Marek Hus, Radosław Mlak et al.|British Journal of Haematology|2020Cited by 24
Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimenAneta Szudy‐Szczyrek, Marek Hus, Radosław Mlak et al.|Annals of Hematology|2020Cited by 23
Role of Non-Coding RNAs in Diagnosis, Prediction and Prognosis of Multiple MyelomaMaciej Dubaj, Iwona Homa‐Mlak, Karol Bigosiński et al.|Cancers|2024Cited by 8